167.16
전일 마감가:
$172.04
열려 있는:
$169.98
하루 거래량:
749.75K
Relative Volume:
1.46
시가총액:
$5.39B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-34.40
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
-6.84%
1개월 성능:
-0.44%
6개월 성능:
+22.01%
1년 성능:
+56.24%
Irhythm Holdings Inc Stock (IRTC) Company Profile
명칭
Irhythm Holdings Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
167.16 | 5.54B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-09-23 | 개시 | Evercore ISI | In-line |
| 2025-08-20 | 개시 | BofA Securities | Buy |
| 2025-05-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Holdings Inc 주식(IRTC)의 최신 뉴스
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86% - simplywall.st
Is It Time To Rethink iRhythm Holdings (IRTC) After The Recent Share Price Pullback - Yahoo Finance
iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst - Benzinga
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Charles River Labs (CRL) and Butterfly Network (BFLY) - The Globe and Mail
SG Americas Securities LLC Trims Stock Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Sees Strong Trading Volume Following Analyst Upgrade - Defense World
iRhythm Technologies (IRTC) Expects 2025 Revenue to Exceed $740 Million, 2026 Revenue of $870 Million - Intellectia AI
Aug Volume: Is NeoGenomics Inc stock undervalued right nowQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land - TechStock²
iRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Intel, Salesforce among market cap stock movers on Tuesday - Investing.com
Earnings Miss: Is iRhythm Technologies Inc stock attractive for income investors2025 Fundamental Recap & Weekly Return Optimization Alerts - Bộ Nội Vụ
Oversold Conditions For iRhythm Holdings (IRTC) - Nasdaq
Wells Fargo & Company Forecasts Strong Price Appreciation for iRhythm Technologies (NASDAQ:IRTC) Stock - MarketBeat
Wells Fargo Raises Price Target for iRhythm Technologies (IRTC) - GuruFocus
RSI Check: Will iRhythm Technologies Inc. stock benefit from infrastructure spendingEarnings Performance Report & Weekly Watchlist for Consistent Profits - moha.gov.vn
iRhythm Technologies (IRTC) Is Down 8.6% After Surpassing 2025 Guidance And Turning Free Cash Flow Positive - Sahm
iRhythm Technologies forecasts 17-18% revenue growth for 2026 By Investing.com - Investing.com Nigeria
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue - TechStock²
Irhythm Technologies, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
IRhythm Technologies, Inc. Updates Earnings Guidance for the Full Year 2025 - marketscreener.com
iRhythm Technologies: Best in Business 2025 - Modern Healthcare
IRTC: Strong growth, profitability, and AI-driven expansion position the business for continued leadership - TradingView — Track All Markets
iRhythm Technologies stock maintains Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Owlet Stock Up More Than 82% in the Past 6 Months: Still Worth Buying? - Finviz
iRhythm Technologies (NASDAQ:IRTC) Receives Buy Rating from Needham & Company LLC - MarketBeat
Needham Reiterates Buy Rating on iRhythm Technologies (IRTC) at $244 | IRTC Stock News - GuruFocus
IRhythm Technologies Provides 2026 Revenue Guidance - marketscreener.com
iRhythm Technologies Reports Strong Preliminary Q4 2025 Results and 2026 Revenue Guidance at J.P. Morgan Healthcare Conference - Quiver Quantitative
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
(IRTC) iRhythm Technologies Expects 2026 Revenue Range $870M to $880M, vs. FactSet Est of $863.6M - marketscreener.com
IRhythm Technologies Inc anticipate FY25 revenue to exceed high end of previously stated guidance range of $740 million provided in October 2025 - marketscreener.com
iRhythm Technologies Inc Anticipate Fy25 Revenue To Exceed High End Of Previously Stated Guidance Range Of $740 Million Provided In October 2025 - TradingView — Track All Markets
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business ... - Bluefield Daily Telegraph
iRhythm Technologies, Inc. Shares Preliminary Fourth - GlobeNewswire
IRhythm Technologies, Inc. (IRTC) Stock Analysis: A 22.76% Upside Potential Beckons Investors - DirectorsTalk Interviews
Trading Systems Reacting to (IRTC) Volatility - Stock Traders Daily
How sustainable is iRhythm Technologies Inc. stock dividend payoutForecast Cut & Long-Term Growth Portfolio Plans - Улправда
iRhythm Technologies (NASDAQ:IRTC) Shares Down 4.8%What's Next? - MarketBeat
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference - TechStock²
iRhythm Technologies $IRTC Shares Sold by Peregrine Capital Management LLC - MarketBeat
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - Sahm
Will iRhythm Technologies Inc. stock deliver better than expected guidance2025 Market Trends & Weekly Market Pulse Alerts - Улправда
What risks investors should watch in iRhythm Technologies Inc. stock2025 Price Momentum & Community Consensus Trade Signals - Улправда
Is iRhythm Technologies Inc. stock trading at a premium valuationMarket Rally & AI Forecasted Entry and Exit Points - Улправда
ulpravda ru > 2026> Why retail investors favor CMCM stockDollar Strength & Verified Trade Idea Suggestions - Улправда
Is iRhythm Technologies Inc. stock a top pick in earnings seasonMarket Activity Summary & High Accuracy Trade Signal Alerts - ulpravda.ru
Will iRhythm Technologies Inc. (I25) stock deliver compounding returnsJuly 2025 Review & Safe Capital Growth Tips - Улправда
Why iRhythm Technologies Inc. stock could see breakout soonWeekly Trend Summary & Daily Chart Pattern Signals - Улправда
Irhythm Holdings Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Irhythm Holdings Inc 주식 (IRTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Murphy Patrick Michael | CBO and CLO |
Dec 02 '25 |
Sale |
184.83 |
2,478 |
458,009 |
53,281 |
자본화:
|
볼륨(24시간):